SCHEMBL17826209

SCHEMBL17826209

CNCc1ccc(-c2nnc(-c3cncc(-c4ccc(S(=O)(=O)CCN(C)C)cc4)n3)o2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 16/20 0.41
▸ SYK P43405 4/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ SERPINA2 P20848 1/20 0.36
▸ PIK3R1 P27986 1/20 0.36
▸ FLT4 P35916 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ GSK3A P49840 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ MAP3K9 P80192 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ MERTK Q12866 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ DYRK2 Q92630 1/20 0.36
▸ CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18177410 0.89 ATR (0.42) ATRSYKJAK2ABL1KIT
SCHEMBL16420658 0.88 ATR (0.44) ATRSYKJAK2ABL1KIT
SCHEMBL16420683 0.87 ATR (0.45) ATRGSK3BPRKDCCA1CA2
SCHEMBL18177411 0.86 ATR (0.43) ATRSYKJAK2ABL1KIT
SCHEMBL16420696 0.86 CA2 (0.38) ATRSYKGSK3BPRKDCCA1
SCHEMBL16420708 0.86 ATR (0.43) ATRSYKJAK2ABL1KIT
SCHEMBL16420659 0.85 ATR (0.48) ATRSYKJAK2ABL1KIT
SCHEMBL2509904 0.84 ATR (0.60) ATRSYKJAK2ABL1KIT
SCHEMBL20278612 0.83 ATR (0.42) ATRSYKJAK2ABL1KIT
SCHEMBL16489024 0.82 ATR (0.52) ATRSYKJAK2ABL1KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365557-B2 Substituted pyrazin-2-amines as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-06-14 — — US disclosed
Send feedback